Immuneering's market cap is currently $53.10M. The company's EPS TTM is $-1.966; its P/E ratio is ―; Immuneering is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 316.95K	$ 2.08M	$ 2.31M	$ 1.92M
Gross Profit	$ -764.14K	$ 158.83K	$ 926.89K	$ 1.03M	$ 696.74K
Operating Income	$ -58.41M	$ -51.74M	$ -33.89M	$ -17.08M	$ -6.29M
EBITDA	$ -58.06M	$ -51.47M	$ -33.68M	$ -17.00M	$ -7.34M
Net Income	$ -53.47M	$ -49.28M	$ -33.54M	$ -17.04M	$ -8.06M
Balance Sheet
Cash & Short-Term Investments	$ 85.67M	$ 105.52M	$ 149.20M	$ 37.09M	$ 13.78M
Total Assets	$ 102.58M	$ 122.37M	$ 166.70M	$ 38.42M	$ 14.10M
Total Debt	$ 4.46M	$ 4.84M	$ 5.36M	$ 621.09K	$ 16.61M
Net Debt	$ -54.94M	$ -67.80M	$ -69.52M	$ -36.47M	$ 2.83M
Total Liabilities	$ 12.01M	$ 12.52M	$ 10.72M	$ 60.90M	$ 20.63M
Stockholders' Equity	$ 90.58M	$ 109.85M	$ 155.98M	$ -22.48M	$ -6.53M
Cash Flow
Free Cash Flow	$ -49.31M	$ -44.84M	$ -30.91M	$ -14.67M	$ -4.46M
Operating Cash Flow	$ -48.97M	$ -44.10M	$ -30.85M	$ -14.62M	$ -4.44M
Investing Cash Flow	$ 7.30M	$ 41.83M	$ -75.62M	$ -53.41K	$ -20.53K
Financing Cash Flow	$ 28.44M	$ 19.00K	$ 144.26M	$ 37.98M	$ 17.17M

Currency in USD

Immuneering Earnings and Revenue History

Income Statement >

Immuneering Debt to Assets

Balance Sheet >

Immuneering Cash Flow

Cash Flow >

Immuneering Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing